Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Rituximab

Brand: 
NICE TA: 
Indication: LMMG RA Biologic Pathway (1st line as Flex 1)
Disease category: Musculoskeletal and joint disease
Commissioning responsibility: CCG
PbR excluded: Yes

Background

Flex 1 as follows:- Rituximab 1st Line: If patient has had cancer within the last 5 years, malignant melanoma at any point, moderate congestive heart failure, ILD

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Red

Red

Red